| __timestamp | Mesoblast Limited | Takeda Pharmaceutical Company Limited |
|---|---|---|
| Wednesday, January 1, 2014 | 55305000 | 382096000000 |
| Thursday, January 1, 2015 | 77593000 | 345927000000 |
| Friday, January 1, 2016 | 50013000 | 312303000000 |
| Sunday, January 1, 2017 | 58914000 | 325441000000 |
| Monday, January 1, 2018 | 65927000 | 368298000000 |
| Tuesday, January 1, 2019 | 59815000 | 492381000000 |
| Wednesday, January 1, 2020 | 56188000 | 455833000000 |
| Friday, January 1, 2021 | 53012000 | 526087000000 |
| Saturday, January 1, 2022 | 32815000 | 633325000000 |
| Sunday, January 1, 2023 | 27189000 | 729924000000 |
| Monday, January 1, 2024 | 25353000 | 729924000000 |
In pursuit of knowledge
In the ever-evolving pharmaceutical industry, research and development (R&D) is the lifeblood of innovation. Over the past decade, Takeda Pharmaceutical Company Limited and Mesoblast Limited have demonstrated contrasting approaches to R&D funding. Takeda, a global leader, has consistently allocated substantial resources, with a notable increase of approximately 91% from 2014 to 2023. In contrast, Mesoblast, a smaller player, has seen a decline of around 54% in the same period.
Takeda's R&D spending surged from 2014's $382 billion to a staggering $730 billion in 2023, reflecting its commitment to pioneering new treatments. Meanwhile, Mesoblast's investment peaked in 2015 but has since dwindled, highlighting the challenges faced by smaller firms in sustaining high R&D expenditure. This divergence underscores the varying strategies and financial capabilities within the pharmaceutical sector, shaping the future of medical advancements.
Research and Development Expenses Breakdown: Novo Nordisk A/S vs Mesoblast Limited
Research and Development Expenses Breakdown: Takeda Pharmaceutical Company Limited vs PTC Therapeutics, Inc.
Takeda Pharmaceutical Company Limited or HUTCHMED (China) Limited: Who Invests More in Innovation?
R&D Spending Showdown: Takeda Pharmaceutical Company Limited vs Vericel Corporation
Who Prioritizes Innovation? R&D Spending Compared for Takeda Pharmaceutical Company Limited and Supernus Pharmaceuticals, Inc.
R&D Spending Showdown: Takeda Pharmaceutical Company Limited vs Evotec SE
Intra-Cellular Therapies, Inc. or Mesoblast Limited: Who Invests More in Innovation?
Comparing Innovation Spending: Ascendis Pharma A/S and Mesoblast Limited
Amneal Pharmaceuticals, Inc. or Mesoblast Limited: Who Invests More in Innovation?
Research and Development Expenses Breakdown: Bausch Health Companies Inc. vs Mesoblast Limited
R&D Spending Showdown: Mesoblast Limited vs Galapagos NV
R&D Insights: How Mesoblast Limited and Celldex Therapeutics, Inc. Allocate Funds